Qinghai Spring Medicinal Resources Technology Co Ltd (600381) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.008x

Based on the latest financial reports, Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a cash flow conversion efficiency ratio of -0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-8.22 Million ≈ $-1.20 Million USD) by net assets (CN¥1.03 Billion ≈ $151.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Qinghai Spring Medicinal Resources Techn's balance sheet to measure how much of total assets are equity-financed.

Qinghai Spring Medicinal Resources Technology Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Qinghai Spring Medicinal Resources Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Qinghai Spring Medicinal Resources Techn to evaluate the quality of earnings relative to operating cash generation.

Qinghai Spring Medicinal Resources Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Qinghai Spring Medicinal Resources Technology Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shenzhen HeKeda Precision Cleaning Equipment Co Ltd SHE:002816	-0.058x
Metropolis Healthcare Limited NSE:METROPOLIS	0.091x
TECHPOINT INC. JDR/1 F:R46	N/A
Accent Group Ltd AU:AX1	0.214x
Cre8 Direct Ningbo Co Ltd SHE:300703	0.055x
JSL S.A SA:JSLG3	0.426x
Byggmax Group AB ST:BMAX	-0.008x
FPT Securities JSC VN:FTS	-0.403x

Annual Cash Flow Conversion Efficiency for Qinghai Spring Medicinal Resources Technology Co Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Qinghai Spring Medicinal Resources Technology Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see Qinghai Spring Medicinal Resources Techn (600381) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥999.61 Million ≈ $146.27 Million	CN¥-26.41 Million ≈ $-3.86 Million	-0.026x	-133.81%
2024-12-31	CN¥1.04 Billion ≈ $151.64 Million	CN¥80.97 Million ≈ $11.85 Million	0.078x	+314.06%
2023-12-31	CN¥1.27 Billion ≈ $185.45 Million	CN¥23.92 Million ≈ $3.50 Million	0.019x	+190.91%
2022-12-31	CN¥1.53 Billion ≈ $224.32 Million	CN¥-31.82 Million ≈ $-4.66 Million	-0.021x	+40.89%
2021-12-31	CN¥1.82 Billion ≈ $266.39 Million	CN¥-63.93 Million ≈ $-9.36 Million	-0.035x	+6.78%
2020-12-31	CN¥2.07 Billion ≈ $302.77 Million	CN¥-77.95 Million ≈ $-11.41 Million	-0.038x	+61.92%
2019-12-31	CN¥2.39 Billion ≈ $349.53 Million	CN¥-236.30 Million ≈ $-34.58 Million	-0.099x	-28.13%
2018-12-31	CN¥2.38 Billion ≈ $348.68 Million	CN¥-183.97 Million ≈ $-26.92 Million	-0.077x	-287.09%
2017-12-31	CN¥2.32 Billion ≈ $339.48 Million	CN¥95.74 Million ≈ $14.01 Million	0.041x	-76.03%
2016-12-31	CN¥2.00 Billion ≈ $293.22 Million	CN¥344.99 Million ≈ $50.48 Million	0.172x	-63.62%
2015-12-31	CN¥1.76 Billion ≈ $257.31 Million	CN¥832.17 Million ≈ $121.77 Million	0.473x	+262.85%
2014-12-31	CN¥308.44 Million ≈ $45.13 Million	CN¥-89.64 Million ≈ $-13.12 Million	-0.291x	+48.24%
2013-12-31	CN¥50.03 Million ≈ $7.32 Million	CN¥-28.09 Million ≈ $-4.11 Million	-0.561x	-72.31%
2012-12-31	CN¥2.15 Billion ≈ $314.92 Million	CN¥-701.18 Million ≈ $-102.61 Million	-0.326x	-402.13%
2011-12-31	CN¥2.32 Billion ≈ $339.20 Million	CN¥249.98 Million ≈ $36.58 Million	0.108x	+117.52%
2010-12-31	CN¥-116.10 Million ≈ $-16.99 Million	CN¥71.47 Million ≈ $10.46 Million	-0.616x	-180.00%
2009-12-31	CN¥-178.12 Million ≈ $-26.06 Million	CN¥39.16 Million ≈ $5.73 Million	-0.220x	-143.65%
2008-12-31	CN¥-230.81 Million ≈ $-33.78 Million	CN¥20.83 Million ≈ $3.05 Million	-0.090x	-367.44%
2007-12-31	CN¥-362.40 Million ≈ $-53.03 Million	CN¥7.00 Million ≈ $1.02 Million	-0.019x	+61.55%
2006-12-31	CN¥-429.60 Million ≈ $-62.86 Million	CN¥21.57 Million ≈ $3.16 Million	-0.050x	-110.15%
2005-12-31	CN¥327.77 Million ≈ $47.96 Million	CN¥162.12 Million ≈ $23.72 Million	0.495x	+616.00%
2004-12-31	CN¥489.71 Million ≈ $71.66 Million	CN¥33.83 Million ≈ $4.95 Million	0.069x	+1796.70%
2003-12-31	CN¥391.64 Million ≈ $57.31 Million	CN¥1.43 Million ≈ $208.72K	0.004x	-91.75%
2002-12-31	CN¥351.79 Million ≈ $51.48 Million	CN¥15.54 Million ≈ $2.27 Million	0.044x	+238.60%
2001-12-31	CN¥333.98 Million ≈ $48.87 Million	CN¥-10.64 Million ≈ $-1.56 Million	-0.032x	-183.07%
2000-12-31	CN¥117.80 Million ≈ $17.24 Million	CN¥4.52 Million ≈ $661.33K	0.038x	-93.81%
1999-12-31	CN¥113.38 Million ≈ $16.59 Million	CN¥70.28 Million ≈ $10.28 Million	0.620x	--

About Qinghai Spring Medicinal Resources Technology Co Ltd

SHG:600381 China Drug Manufacturers - Specialty & Generic

Market Cap

$318.71 Million

CN¥2.18 Billion CNY

Market Cap Rank

#14334 Global

#4165 in China

Share Price

CN¥3.71

Change (1 day)

-1.85%

52-Week Range

CN¥2.61 - CN¥5.70

All Time High

CN¥24.91